A novel mutation in the CIAS1/NLRP3 gene associated with an unexpected phenotype of cryopyrin-associated periodic syndromes

Clinical and Experimental Rheumatology

Volumn 32, Issue 1, 2014, Pages 123-125

  Insalaco, Antonella ^a   Prencipe, Giusi ^a   Buonuomo, Paola S ^a   Ceccherini, Isabella ^b   Bracaglia, Claudia ^a   Pardeo, Manuela ^a   Nicolai, Rebecca ^a   De Benedetti, Fabrizio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Angioedema; CAPS; Novel; Pericarditis; Rash

Indexed keywords

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CARRIER PROTEINS; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MUTATION; PHENOTYPE; TREATMENT OUTCOME;

EID: 84894032236     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. SAVIC S, DICKIE LJ, BATTELLINO M, MCDERMOTT MF: familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases. Curr Opin Rheumatol 2012; 24: 103-12.
2. GOLDBACH-MANSKY R: Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clin Exp Immunol 2012; 167: 391-404.
3. KUEMMERLE-DESCHNER JB, HACHULLA E, CARTWRIGHT R et al.: Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes. Ann Rheum Dis 2011; 70: 2095-102.
4. GOLDBACH-MANSKY R: Current status of understanding the pathogenesis and management of patients with NOMID/CINCA. Curr Rheumatol Rep 2011; 13: 123-31.
5. Ter HAAR N, LACHMANN H, ÖZEN S et al.: treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis 2013; 72: 678-85.
6. AKSENTIJEVICH I, DPUTNAM C, REMMERS EF et al.: The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum 2007; 56: 1273-85.
7. VERMA D, LERM M, BLOMGRAN JULINDERR, ERIKSSON P, SÖDERKVIST P, SÄRNDAHLE: Gene polymorphisms in the NALP3 inflammasome are associated with interleukin- 1 production and severe inflammation: relation to common inflammatory diseases?. Arthritis Rheum 2008; 58: 888-94.
8. VITALE A, LUCHERINI OM, GALEAZZI M, FREDIANI B, CANTARINI L: Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series. Clin Exp Rheumatol 2012; 30: 943-6.
9. GATTORNO M, TASSI S, CARTA S et al.: Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum 2007; 56: 3138-48.